Data / Form D filings / BOREAL GENOMICS INC.
BOREAL GENOMICS INC.: Form D filings
BOREAL GENOMICS INC., a biotechnology company in Vancouver, British Columbia, Canada, filed 2 Form D notices with the SEC between 2010 and 2013. The latest, on October 11, 2013, reports $18 million sold of a $18 million offering to 5 investors.
Find out what BOREAL GENOMICS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2386 EAST MALL., Vancouver, British Columbia, Canada, V6T1Z
- Phone
- (604) 822-8268
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1505963
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 11, 2013 | New notice | $17,999,997 | $17,999,997 | $0 | 5 | Sep 30, 2013 | sec.gov |
| Dec 16, 2010 | New notice | $6,499,999 | $6,499,999 | $0 | 4 | Oct 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| THOMAS WILLIS | Executive Officer, Director | |
| DAVID BROEMELING | Executive Officer | |
| KEITH CRANDELL | Director | |
| NITIN SOOD | Executive Officer, Director | |
| ANDREA MARZIALI | Executive Officer, Director | |
| CALEY CASTELEIN | Director |
Every Form D from the week of Oct 7, 2013 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BOREAL GENOMICS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.